• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

UMN Medical School’s Center for Magnetic Resonance Research receives NIH U01 grant

Bioengineer by Bioengineer
September 29, 2017
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The University of Minnesota Medical School's Center for Magnetic Resonance Research (CMRR) has been awarded a grant from the National Institutes of Health's BRAIN Initiative. The project will develop new, efficient and safe stimulation paradigms for Deep Brain Stimulation (DBS), which is used to treat common symptoms of neurological disorders including Parkinson's Disease.

"Our work has the potential to revolutionize neuromodulation strategies by increasing the precision with which the technology can target specific pathways in the brain," says principal investigator Shalom Michaeli, Ph.D. The novel DBS system, he says, can be configured not only to generate unidirectional fields for orientation-selective stimulation but also to produce rotating electrical field gradients for modulation of neuronal activity regardless of axon orientations.

The grant is part of an NIH BRAIN Initiative program, "New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (U01)," which has awarded a total of $3.5 million over three years to the research teams with the University of Minnesota, Columbia University and the A.I. Virtanen Institute at the University of Eastern Finland.

"This work is critical for addressing the shortcomings in current DBS technology," says Dr. Michaeli. "By furthering our understanding of DBS mechanisms in humans we can potentially improve treatment quality for patients with disabling neurological symptoms."

Collaborating research teams within the University of Minnesota include the CMRR (S. Michaeli, S. Mangia, D. Idiyatullin and L. Lehto), Department of Neurosurgery (W. Low), Department of Neurology (G. Molnar), and the Department of Biomedical Engineering (M. Johnson). University of Minnesota researchers will combine expertise with their colleagues from Columbia University (Dr. K. Shepard, Electrical Engineering) and A.I. Virtanen Institute, Finland (Drs. O. Gröhn and H. Tanila).

NIH Grant Number: 1U01NS103569-01

###

Media Contact

Naomi McDonald
[email protected]
612-301-9525

https://www.med.umn.edu/

Share12Tweet7Share2ShareShareShare1

Related Posts

blank

CK2–PRC2 Signal Drives Plant Cold Memory Epigenetics

August 2, 2025
blank

AI-Driven Protein Design Advances T-Cell Immunotherapy Breakthroughs

August 1, 2025

Melanthiaceae Genomes Reveal Giant Genome Evolution Secrets

August 1, 2025

“Shore Wars: New Study Tackles Oyster-Mangrove Conflicts to Boost Coastal Restoration”

August 1, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    38 shares
    Share 15 Tweet 10
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unraveling EMT’s Role in Colorectal Cancer Spread

Gut γδ T17 Cells Drive Brain Inflammation via STING

Agent-Based Framework for Assessing Environmental Exposures

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.